At present, kits for target sequencing are available for other Illumina systems, e.g., TruSight Myeloid Sequencing Panel, targeting 54 genes, including CEBPA, NPM1 and FLT3-ITD, or AmpliSeq for Illumina Myeloid Panel, targeting 40 DNA genes, 29 RNA fusion driver genes, and 5 gene expression levels associated with myeloid cancers, including AML. Here, CEBPA is linked to acute myeloid leukemia.